SIA Offers Model For Collaborative Cosmetics Regulatory Reform – EWG
This article was originally published in The Rose Sheet
Notwithstanding widely voiced frustrations with FDA’s implementation of the Sunscreen Innovation Act, Environmental Working Group staff attorney Tina Sigurdson maintains the SIA is a success story, reflecting stakeholder collaborations that can serve as a model to emulate as legislative efforts to update FDA’s cosmetics program go forward.
You may also be interested in...
The Sunscreen Innovation Act may have served to clear FDA’s queue of pending sunscreen TEAs, but with denials across the board due to insufficient data, the Public Access to Sunscreens coalition questions the tenability of FDA’s standards and approach to review. The denial of L’Oreal’s TEA for ecamsule, an ingredient already available OTC through a new drug approval, only reinforces PASS’ view that FDA is resistant to working outside of the NDA pathway.
Prospects for the developing draft bill are optimistic given the California democratic senator’s reputation for working “effectively across the aisle” and her receptivity to both industry and NGO stakeholders. Janet Nudelman, co-founder of the Campaign for Safe Cosmetics, says the legislation will pick up where negotiations between FDA and industry left off earlier in 2014.
Cosmetics Industry Awaits ‘Critical’ Safety Assessment Clarification Under China’s New Framework Reg
The China State Council’s January approval of an overarching Cosmetics Supervision and Administration Regulation promises to bring about long-awaited reforms. But draft regulations targeted for release in coming months will be key to the implementation of CSAR provisions, the Personal Care Products Council says.